3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Meet Veristat at BIO CHINA International Convention 2025
Discover what makes Veristat a distinguished name in the life sciences industry. Veristat is a scientific-minded global clinical research organization (CRO) and consultancy that integrates full-service clinical trial execution, regulatory consulting, and strategic planning to accelerate the development, approval, and commercialization of groundbreaking therapies worldwide.
Join Veristat at BIOCHINA 2025, China’s largest biotech convention and hub for innovation and collaboration. The event runs from March 13-15, 2025, in Suzhou, featuring advances in cell and gene therapy, antibody drugs, vaccines, small molecules, peptides, and nucleic acids. Schedule a meeting with Veristat and discover how we can assist with your clinical research and regulatory requirements across Asian markets and beyond.
Veristat Attendees:
Delphine Guérin - Business Development Director
Conference Details:
Date: March 13-15, 2025
Location: Suzhou International Expo Center
Schedule a Meeting:
Fill out the form to schedule a meeting with Delphine and explore how Veristat can accelerate your clinical trials, regulatory submissions, and market access strategies toward success..
Learn more about the conference
3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...